Pharmacy India
Pharmacy India is your ultimate destination for pharmacy exam preparation and career advancement. Discover top-notch study materials, daily quizzes, and expert courses for pharmacy exams like RRB Pharmacist, GPAT, and NIPER JEE, D.Pharma Exit Exam, etc.
In a significant development, the proposed National Pharmacy Commission Bill 2023 is causing ripples within the pharmaceutical community. Dr. BR Jagashetty, former National Adviser (Drugs Control) to the Union health ministry and former Karnataka State Drugs Controller, sheds light on the potential shift in focus from the profession to education in this groundbreaking legislative change.
In a significant stride towards providing affordable healthcare and empowering pharmacists as micro-entrepreneurs, Generic Aadhar, the largest pharma retail chain store, has celebrated Diwali by adding 111 new franchise outlets to its network. This move aligns with the company’s vision to make high-quality medicines accessible at reasonable prices while creating employment opportunities across the nation.
In a recent development, the Delhi High Court has extended an eight-week deadline to the Central government to formulate a comprehensive policy addressing concerns surrounding the online sale of drugs. Acting Chief Justice Mini Pushkarna emphasized that ample time had passed, with over five years elapsing since the publication of a draft notification. This decision was made during a hearing on a petition filed by Dr. Zaheer Ahmed, the South Chemists and Distributors Association (SCDA), and others, highlighting the government’s inaction on e-pharmacies.
In a significant stride toward bolstering pharmaceutical safety standards, the proposed Revised Schedule M guidelines are set to usher in a comprehensive system for prompt and effective drug recall. Dr. S Eswara Reddy, Joint Drugs Controller at the Central Drugs…
In a significant development, Jagannath Shinde, President of The All India Organisation of Chemists and Druggists (AIOCD), has emphatically declared the organization’s staunch resistance against the establishment of the proposed National Pharmacy Commission. The move comes in the wake of plans to repeal the Pharmacy Act and replace the Pharmacy Council of India (PCI). Shinde, a seasoned pharmacy professional, asserts that AIOCD is prepared to fiercely combat any attempt to transfer control of the pharmacy profession from pharmacists to bureaucrats.
As the anticipated Draft National Pharmacy Commission Bill, 2023, prepares to replace the longstanding Pharmacy Act, 1948, substantial clarifications and transitional provisions have emerged, shedding light on the future of pharmacy regulation in India. The draft Bill explicitly outlines that while the Pharmacy Act, 1948, will be repealed upon the new enactment, the educational standards, requirements, and other provisions of the original Act will persist until new standards are specified under the new Bill. This forward-looking approach aims to ensure a seamless transition without compromising the existing educational framework.
Exciting news for PhD scholars at the National Institutes of Pharmaceutical Education & Research (NIPER)! The Department of Pharmaceuticals (DoP) has given its nod for a significant revision in the fellowship rates, aligning them with the latest standards approved by the Department of Higher Education. Effective January 1, 2023, this revision promises enhanced emoluments for scholars, marking a positive shift in the support provided to those engaged in pharmaceutical research.
In a groundbreaking initiative to revolutionize healthcare accessibility, Redwing, in collaboration with the Samridh Healthcare Blended Finance Facility, has introduced a pilot drone network in the Rayagada district of Odisha. Supported by the United States Agency for International Development (USAID) and implemented by IPE Global, this innovative project aims to address the challenges faced by the predominantly tribal Rayagada district in accessing vital healthcare services.
In a recent study backed by the National Institutes of Health (NIH), chronic sleep deficiency is found to elevate insulin resistance, particularly in postmenopausal women, emphasizing the crucial role of proper sleep in reducing the risk of type 2 diabetes.
The proposed National Pharmacy Commission Bill, 2023 introduces significant changes to the regulation of pharmacy education, services, training, and research in India. The key highlight is the establishment of a new advisory body called the Pharmacy Advisory Council, which aims to play a pivotal role in advising the National Pharmacy Commission (NPC). Under this draft bill, the Advisory Council will serve as a primary platform for States and Union Territories to communicate their perspectives and concerns to the Commission. This advisory body is designed to contribute to the shaping of the overall agenda, policy, and actions related to pharmacy education, services, training, and research.
